NCT07250646 A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis Status NOT_YET_RECRUITING Phase PHASE1
NCT07211178 Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies Status RECRUITING Phase N/A
NCT07154823 A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies Status RECRUITING Phase N/A
NCT06997458 Liquid BiOpsy, Lung and Colon Cancer in AndaluciA Status ENROLLING_BY_INVITATION Phase N/A
NCT06911632 Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension Status RECRUITING Phase NA
NCT06163534 A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC) Status RECRUITING Phase N/A
NCT06126003 Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer. Status TERMINATED Phase N/A
NCT06099665 Addressing Under-treatment and Health Equity in AS and MR Using an Integrated EHR Platform Status COMPLETED Phase NA
NCT06051695 A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression Status RECRUITING Phase PHASE1/PHASE2
NCT06018753 Umbrella Study for Analysis of Data Related to Patients With Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05736731 A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05442203 Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease Status ACTIVE_NOT_RECRUITING Phase NA
NCT05234177 Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays Status RECRUITING Phase N/A
NCT05179824 Tempus Priority Study: A Pan-tumor Observational Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05169437 Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors Status TERMINATED Phase PHASE2
NCT04981119 Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing Status RECRUITING Phase N/A